《臨床與轉(zhuǎn)化腫瘤學(xué)》是一本致力于促進(jìn)實(shí)驗(yàn)?zāi)[瘤學(xué)與臨床腫瘤學(xué)相互作用的國際期刊。它涵蓋了癌癥研究的所有方面，從涉及腫瘤細(xì)胞和分子生物學(xué)的更基本的發(fā)現(xiàn)，到最先進(jìn)的傳統(tǒng)和新藥的臨床檢測(cè)。此外，該雜志致力于促進(jìn)從基礎(chǔ)實(shí)驗(yàn)室到臨床實(shí)踐的知識(shí)轉(zhuǎn)移，出版了一系列致力于縮小分子腫瘤學(xué)家和臨床腫瘤學(xué)家之間差距的教育系列。腫瘤分子生物學(xué)、癌癥診斷生物標(biāo)記物的識(shí)別、治療反應(yīng)的預(yù)后或預(yù)測(cè)、癌癥治療新靶點(diǎn)的識(shí)別以及癌癥研究和治療新技術(shù)的開發(fā)是教育系列和研究文章的主題。將考慮發(fā)表廣泛的主題，包括疾病的分子和細(xì)胞基礎(chǔ)、病因?qū)W、病理生理學(xué)、病理學(xué)、流行病學(xué)、臨床特征以及癌癥的診斷、預(yù)后和治療。

Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of biomarkers for cancer diagnosis, prognosis or prediction of treatment response, identification of new targets for cancer therapy, as well as development of new technologies for research and treatment of cancer are the major themes covered by both the educational series and research articles. A broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.